University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 2 of 13
COES: Curing Order Effects on Sealants
NCT06342258
Abuse Liability and Appeal of Oral Nicotine Products
NCT06506162
Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery
NCT06815367
Access to Genetic Testing in Underserved Patients With Cancer
NCT06422455
Effect of a Fasting Mimicking Diet on Patients With Multiple Sclerosis (FMDMS)
NCT06515782
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NCT06500169
Reducing Blood Pressure in Patients With High Cardiovascular Risk
NCT05937685
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
NCT05867381
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
NCT06060873
Sensory Optimization of the Hospital Environment
NCT05230199
Vascularized Composite Bladder Allograft Transplantation
NCT05462561
Keck Medicine of University of Southern California Thrive Study
NCT05780892
Trazodone vs. Quetiapine for the Treatment of ICU Delirium
NCT05307003
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
NCT05791448
Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy
NCT05781438
HEPA, PM2.5, and Cardiometabolic Health
NCT05718245
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
NCT06067295
Cognition and Motor Learning Post-stroke
NCT04829071
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
NCT05634356
Confronting Cancer as a Community
NCT06063928
Breast Cancer Survivorship Biorepository
NCT05786664
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
NCT04469790
Model-based Electrical Brain Stimulation
NCT05327387
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
NCT05746143
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation
NCT05307055
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
NCT07312162
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT07259304
Smart Boot Use to Measure Offloading Adherence
NCT04460573
Cefixime Clinical Trial
NCT04958122
Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms
NCT04923477
Trial-Ready Cohort-Down Syndrome (TRC-DS)
NCT04165109
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
NCT04734847
Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
NCT04524247
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
NCT06171607
Duration of Urinary Catheterization
NCT04359069
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT04333706
Encoding Temporal Fine Structure for Cochlear Implants
NCT04708717
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
NCT03858205
In-Utero Endoscopic Correction of Spina Bifida
NCT04362592
Gentamicin for Junctional Epidermolysis Bullosa
NCT03526159
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
NCT03568266
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
NCT03921047
Alzheimer Prevention Trials (APT) Webstudy
NCT03638583
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854
Norris ORIEN Total Cancer Care
NCT02970045
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
NCT02434393
Core Biopsies for Establishing a Breast Tumor Tissue Repository
NCT02250352
Commensality Groups: A Professional Fulfillment Intervention for Medical Students in Their Clinical Years
NCT06656650
The Study in Outpatient Medicine Using Nudges to Improve Sleep
NCT06640023
Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion
NCT07587619
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Southern California pipeline card: 617 registered trials from official public datasets.Report a data error.